Palantir's UK Reckoning: A £330 Million NHS Contract Hangs on a December Deadline

Over 120 European groups urge Brussels to bar Palantir from public tenders, as UK ministers weigh the NHS data platform's future by December.

More than 120 European organizations and trade unions turned up the heat on Brussels this week, demanding that EU governments and institutions tear up their existing contracts with Palantir Technologies and bar the US data analytics firm from all future public tenders. The coordinated push strikes directly at the company's core business model: wiring government administrations into centralized software platforms.

The timing could hardly be more awkward. Palantir is simultaneously racing to expand its sovereign AI footprint, and the contradiction between its security-sector credentials and its civilian reputation is widening by the week.

A Prestige Project on the Line in London

Nowhere is the friction more concrete than in Britain. Campaigners from the healthcare sector pressed the UK government on Tuesday to let the contract for the NHS Federated Data Platform lapse — a deal worth as much as £330 million across a seven-year term. The decision now rests with government ministers, who must determine by December whether to trigger an agreed exit clause.

Losing this flagship reference customer in European healthcare would deal a serious blow to Palantir's ambition to embed itself more broadly in civilian government apparatus across the continent. The NHS insists patient data stays in the country and is not used for commercial purposes, but the mistrust runs deep. For investors, the resistance is not mere ideological noise — it is a tangible business risk. Europe remains difficult terrain for US tech firms, where data protection concerns and sovereignty questions can sink contracts of considerable size.

The pressure extends beyond Britain. In Australia, Palantir hired lobbyist Stephen Conroy to smooth relations after losing a major contract with retailer Coles, with federal contracts worth $17 million hanging in the balance. In the US, a lawsuit alleges that the immigration authority ICE used Palantir's database to compile dossiers on protest participants. CEO Alex Karp warned in July that excessive regulation amounts to a brake on innovation, yet the current controversies stem less from bureaucratic hurdles than from fundamental questions of public trust. When private-sector customers or sensitive agencies walk away over reputational concerns, the business model loses its most important expansion base outside the Pentagon.

Building the Infrastructure Moat

On the technology front, the company is pressing ahead regardless. A new partnership with US provider Armada will integrate Palantir's Sovereign AI Operating System into modular data systems, combining it with Armada's Galleon modular data centers, the Armada Platform and the Sovereign AI Grid. Under the arrangement, Armada becomes Palantir's first Certified Modular Data Center Partner. Financial terms and the expected revenue contribution were not disclosed.

The strategic direction is clear: Palantir wants its software deployable wherever standardized cloud infrastructure hits its limits. Separately, the company unveiled a framework with Rackspace aimed at financial and healthcare institutions, designed to safeguard the use of artificial intelligence on sensitive data sets. These initiatives underscore a fundamental strength — few software firms match Palantir's ability to deliver complex data architectures for security-critical environments.

Insider Allocations and the Numbers Ahead

While the strategic pieces move into place, the leadership ranks secured fresh shares. According to mandatory filings, Chief Financial Officer David A. Glazer and Ryan D. Taylor — who serves as both Chief Revenue Officer and Chief Legal Officer — each received 92,908 Class A common shares on Tuesday at a reported value of $0 per share. Jeffrey Buckley, the Chief Accounting Officer, simultaneously received 16,714 immediately exercisable stock appreciation rights with an exercise price of $186.97 per share.

Market observers expect third-quarter results, due on November 2, to show revenue of $2.22 billion, according to consensus estimates. In the second quarter of 2026, revenue still climbed 93 percent year over year. For the full year 2026, management is targeting annual revenue of $8.15 billion to $8.16 billion.

Markets Shrug — For Now

Equities have so far taken the mix of political pressure and operational expansion in stride. The stock closed Friday at €167.70, a modest daily decline of 0.8 percent, leaving it just 6.8 percent below its 52-week high of €179.98. Investors appear willing to bet that new technology partnerships can offset turbulence in Europe.

Even so, the December deadline in London marks a test case. It will show how resilient Palantir's footing in European government machinery really is — and whether a company that thrives on state entanglement can keep growing at its current pace when that entanglement becomes a liability.